Topics

Articles

The company’s latest investment—featuring new cGMP suites at its Devens, MA plant—is valued at $30 million.

Veranova Expands Its Financial Commitment Toward Growing Highly Potent API Services

The North Carolina project adds 1.4 million square feet of dedicated production space for aseptic manufacturing and finished production processes.

Novo Nordisk Financially Commits $4.1 Billion Toward Growing US Manufacturing Capabilities

The company acquires Alimera Sciences for $381 million upfront, while establishing its interest in ophthalmology.

ANI Pharmaceuticals Expands Rare Disease Offerings

Podcasts

Mark Bouck discusses PharmAlliance’s latest acquisitions, while reiterating its goals surrounding health economics and outcomes research.

Navigating Market Access Hurdles

The acquisition of the 87,000 square-foot Camden, MD plant provides the CDMO with the ability to offer clinical and commercial non-viral aseptic fill-finish services on four fill lines.

Bora Pharmaceuticals to Purchase Emergent’s Sterile Manufacturing Facility 

Deal will target neurological diseases, featuring an initial payment of $42 million for Ascidian and up to $1.8 billion in milestone payments/royalties.

Ascidian Therapeutics, Roche Enter RNA Exon Editing Therapeutics Collaboration

An analysis of the general medicine portion of the pharmacy market amid ensuing challenges.


Who Moved My Prescription? Part IV: The Rise of Cash Pharmacy

Financial commitment will go toward expanding the CDMO’s integrated antibody-drug conjugate services.

Sterling Pharma Solutions to Invest $3 Million in Germantown, WI Plant

The deal grows it pipeline, powered by panCAR programs in autoimmune disease and oncology.

Orna Therapeutics Enhances Circular RNA Capabilities, Acquires ReNAgade Therapeutics 

With the acquisition, Merck’s US and Canada life science business aims to further increase its viral vector manufacturing capabilities.

Business and Finance